DAPCEL Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • DAPCEL's estimated annual revenue is currently $775k per year.(i)
  • DAPCEL's estimated revenue per employee is $155,000

Employee Data

  • DAPCEL has 5 Employees.(i)
  • DAPCEL grew their employee count by 0% last year.

DAPCEL's People

NameTitleEmail/Phone
1
CEO, PresidentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$1.7M110%N/AN/A
#3
$0.8M50%N/AN/A
#4
$5.1M3314%N/AN/A
#5
$64.6M4172%N/AN/A
#6
$1.7M11-8%N/AN/A
#7
$0.8M50%N/AN/A
#8
$7.4M48-41%N/AN/A
#9
$0.6M40%N/AN/A
#10
$0.9M1220%N/AN/A
Add Company

What Is DAPCEL?

Supporting life science research since 2008, DAPCEL, Inc. is the trusted source for the innovative Two-Layered DAPCEL RC (Rare Codon) Gene Optimization strategy for recombinant protein production as well as high-quality protein and cell line services and products. DAPCEL, Inc was cofounded by Natalia Tararova, MS, CEO, President and Anton A. Komar, PhD, CSO, Director and represents a perfect example of a successful technology transfer from basic science to industry. DAPCEL, Inc. partners with PeproTech Inc., Biocompare, Antibodies Online and many other companies and academic institutions around the globe. DAPCEL is dedicated to solving complex protein problems through innovation. If you are looking for quality – choose DAPCEL, Inc services and products! The Mission of DAPCEL, Inc. is: • To develop and support innovative gene redesign strategies allowing production of correctly folded, soluble and active recombinant proteins in any desired host organism. • To best serve our customers by providing them with services ranging from gene codon optimization to custom protein/antibody production and the state-of-the-art bioactivity assays. • To provide our customers with superior quality products ranging from recombinant proteins to various cell lines. • To develop and expand partnerships with relevant industrial and academic institutions. • To always keep highest quality standards. DAPCEL, Inc is known worldwide for its unbeatable gene optimization strategy for recombinant protein production in any desired host organism. DAPCEL, Inc has also recently launched a line of new and improved products, including, but not limited to: • Oncostatin M of highest specific activity and lowest price! • TGF-beta of great and uniform lot-to-lot reproducibility! • Immortalized HUVECs! • Superior quality PBMCs! • State-of-the-art cell invasion and cell migration assays!

keywords:N/A

N/A

Total Funding

5

Number of Employees

$775k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M5-17%N/A
#2
$0.1M5-37%$4M
#3
$0.4M50%N/A
#4
$0.4M567%N/A
#5
$0.4M50%N/A